EATG » CROI 2018

CROI 2018

HIV i-Base: HTB, special CROI issue

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. As CROI is a conference that keeps on giving, this issue of HTB continues with further reports from…

CROI 2018: Researchers puzzle over whether HIV accelerates cancer progression

Although people living with HIV may be diagnosed with cancer at an earlier stage because they get more consistent care than the general population, it is also possible that a…

CROI 2018: Research is still exploring best treatment strategies for pregnant and breastfeeding women, interactions with contraceptives

Although women comprise more than half of adults living with HIV across the globe, they are considered a special population worthy of more intensive research. Now, several new studies presented…

CROI 2018: 8-week course of Zepatier cures acute HCV in people with HIV

An 8-week course of grazoprevir/elbasvir (Zepatier) produced sustained virological response in most HIV-positive gay men with recent hepatitis C virus (HCV) genotype 1 or 4 infection, according to a presentation…

HIV i-Base: HTB, special CROI issue

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. This is the second issue of HTB to lead with reports from CROI 2018, the main annual HIV…

CROI 2018: Highlights and what’s next for advocates

Historically, the Conference on Retroviruses and Opportunistic Infections (more commonly known as CROI) is heavy on basic science and early-phase research. Data from these types of studies were still prominent…

CROI 2018: South Africa: women may have higher rates of HIV than men because fewer men are on treatment

South African researchers presenting a study at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2018) have suggested that the reason the extremely high rates of HIV infection in…

CROI 2018: Rapid HIV care cuts time to viral suppression in half

With the help of his local health department in New Orleans, Jason Halperin, MD, and colleagues are starting patients on ART within 72 hours of their HIV diagnosis — most…

CROI 2018: Reported PrEP ‘failure’ most likely a lack of proper testing and adherence

When is a pre-exposure prophylaxis (PrEP) failure actually a provider failure? And how do we tell the difference? This was a question that came up at CROI 2018 after a…

CROI 2018: How HIV alters cells may facilitate sexual transmission of hepatitis C

A new study identifies key changes that HIV makes to Langerhans cells in the mucosal lining of the rectum. HIV apparently leads to changes to a particular kind of immune…

1 2 3 8